My view is that they still need to verify that a "band" type device will provide the same FDA-approved data as the Xcel/ Pulse if we're going to pursue a strategy of either releasing our own band or licensing the technology-on-a-chip to others e.g. via their band/ oura-ring, etc).
Otherwise we will not have a ubiquitous heart-health data strategy (in the millions) and we will always be limited to data from our devices - therefore a smaller TAM.... my two cents worth.
Add to My Watchlist
What is My Watchlist?
